OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
300856$14.1059

Nanjing COSMOS Chemical Co Ltd

Specialty ChemicalsVerified

Nanjing COSMOS Chemical Co Ltd has a market capitalization of 6.71 billion CNY and a price-to-earnings ratio of 62.08, indicating a high valuation relative to earnings. The company's price-to-book ratio of 2.41 suggests that the market values the company at a premium to its book value. The enterprise value to EBITDA ratio of 62.88 further reinforces the high valuation, indicating that the company is trading at a multiple significantly above industry norms. Profitability metrics show a return on equity of 3.88% and a return on assets of 2.56%, both of which are below the typical performance of the specialty chemicals industry. The company's gross profit margin is 29.43%, and its operating margin is 7.95%, which are in line with the industry but do not indicate a competitive advantage. The net profit margin of 7.28% reflects the company's ability to convert revenue into profit, but it is not significantly higher than the industry median. The company's capital structure is characterized by a debt-to-equity ratio of 0.25, indicating a relatively conservative leverage position. The current ratio of 3.45 suggests strong short-term liquidity, with the company holding sufficient current assets to cover its current liabilities more than three times over. However, the company's free cash flow is negative at -339.03 million CNY, which may limit its ability to fund growth initiatives without external financing. Geographically, the company's revenue is concentrated in its domestic market, with no significant international exposure disclosed in the financial data. The company operates in a single business segment, which may increase its exposure to sector-specific risks. The lack of diversification could be a concern if the domestic market experiences a downturn. Looking ahead, the company's revenue is expected to grow, supported by its position in the specialty chemicals industry and the demand for its products. However, the high valuation multiples suggest that the market is pricing in significant future growth, which may be difficult to sustain. The company's capital expenditure of -512.21 million CNY indicates a significant investment in infrastructure and capacity expansion. This investment could support future growth but may also strain the company's liquidity in the short term. Recent filings and transcripts do not indicate any material changes in the company's operations or strategy. The company's liquidity risk is rated as medium, primarily due to its negative net cash position after accounting for total debt. The risk of dilution is low, as the company has not issued additional shares recently, and there is no indication of a pending equity offering. The company's credit risk is moderate, given its strong liquidity position and conservative leverage.

30-day price · 300856+1.63 (+13.4%)
Low$12.08High$14.89Close$13.80As of21 May, 00:00 UTC
Profile
CompanyNanjing COSMOS Chemical Co Ltd
Ticker300856.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Nanjing COSMOS Chemical Co Ltd is a specialty chemicals company that produces and sells chemical products, primarily serving industrial and manufacturing sectors.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Nanjing COSMOS Chemical Co Ltd has a market capitalization of 6.71 billion CNY and a price-to-earnings ratio of 62.08, indicating a high valuation relative to earnings. The company's price-to-book ratio of 2.41 suggests that the market values the company at a premium to its book value. The enterprise value to EBITDA ratio of 62.88 further reinforces the high valuation, indicating that the company is trading at a multiple significantly above industry norms. Profitability metrics show a return on equity of 3.88% and a return on assets of 2.56%, both of which are below the typical performance of the specialty chemicals industry. The company's gross profit margin is 29.43%, and its operating margin is 7.95%, which are in line with the industry but do not indicate a competitive advantage. The net profit margin of 7.28% reflects the company's ability to convert revenue into profit, but it is not significantly higher than the industry median. The company's capital structure is characterized by a debt-to-equity ratio of 0.25, indicating a relatively conservative leverage position. The current ratio of 3.45 suggests strong short-term liquidity, with the company holding sufficient current assets to cover its current liabilities more than three times over. However, the company's free cash flow is negative at -339.03 million CNY, which may limit its ability to fund growth initiatives without external financing. Geographically, the company's revenue is concentrated in its domestic market, with no significant international exposure disclosed in the financial data. The company operates in a single business segment, which may increase its exposure to sector-specific risks. The lack of diversification could be a concern if the domestic market experiences a downturn. Looking ahead, the company's revenue is expected to grow, supported by its position in the specialty chemicals industry and the demand for its products. However, the high valuation multiples suggest that the market is pricing in significant future growth, which may be difficult to sustain. The company's capital expenditure of -512.21 million CNY indicates a significant investment in infrastructure and capacity expansion. This investment could support future growth but may also strain the company's liquidity in the short term. Recent filings and transcripts do not indicate any material changes in the company's operations or strategy. The company's liquidity risk is rated as medium, primarily due to its negative net cash position after accounting for total debt. The risk of dilution is low, as the company has not issued additional shares recently, and there is no indication of a pending equity offering. The company's credit risk is moderate, given its strong liquidity position and conservative leverage.
Key takeaways
  • The company is trading at a high valuation, with a price-to-earnings ratio of 62.08 and an enterprise value to EBITDA ratio of 62.88.
  • Profitability metrics are in line with the industry but do not indicate a competitive advantage.
  • The company has a conservative capital structure with a debt-to-equity ratio of 0.25 and a strong current ratio of 3.45.
  • The company's revenue is concentrated in its domestic market, and it operates in a single business segment.
  • The company is investing in capital expenditures, which could support future growth but may strain liquidity in the short term.
  • The risk of dilution is low, and the company's liquidity risk is rated as medium.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.48B
Gross profit$436.5M
Operating income$117.9M
Net income$108.0M
R&D
SG&A
D&A
SBC
Operating cash flow$287.6M
CapEx-$512.2M
Free cash flow-$339.0M
Total assets$4.22B
Total liabilities$1.44B
Total equity$2.78B
Cash & equivalents
Long-term debt$704.0M
Valuation
Market price$14.10
Market cap$6.71B
Enterprise value$7.41B
P/E62.1
Reported non-GAAP P/E
EV/Revenue5.0
EV/Op income62.9
EV/OCF25.8
P/B2.4
P/Tangible book2.4
Tangible book$2.78B
Net cash-$704.0M
Current ratio3.5
Debt/Equity0.2
ROA2.6%
ROE3.9%
Cash conversion2.7%
CapEx/Revenue-34.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric300856Activity
Op margin7.9%0.4% medp25 -8.0% · p75 16.0%above median
Net margin7.3%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin29.4%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-34.5%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity25.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean price target18.05 CNY
Median price target18.05 CNY
High price target20.00 CNY
Low price target16.10 CNY
Mean recommendation1.50 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.40 CNY
Last actual EPS0.23 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 05:19 UTCJob: 3239a77e